Table 1 Baseline data for patients with tight versus standard blood pressure control
Variables | TBPC (SBP < 130 mmHg) (n = 4530) N (%) | SBPC (SBP 130–139 mmHg) (n = 1110) N (%) | P valuea |
|---|---|---|---|
Age category | < 0.001 | ||
40 to 49 years | 778 (17.2) | 183 (16.5) | |
50 to 59 years | 1533 (33.8) | 330 (29.7) | |
60 to 69 years | 1466 (32.4) | 339 (30.5) | |
70 to 79 years | 753 (16.6) | 258 (23.2) | |
Gender | 0.504 | ||
Male | 1917 (42.3) | 482 (43.4) | |
Female | 2613 (57.7) | 628 (56.6) | |
Race | < 0.001 | ||
African American | 1235 (27.3) | 406 (36.6) | |
Asian | 152 (3.4) | 26 (2.3) | |
Hispanic | 58 (1.3) | 13 (1.2) | |
White | 2588 (57.1) | 550 (49.5) | |
Other/unknown | 497 (11.1) | 115 (10.4) | |
BMI category | < 0.001 | ||
Underweight | 50 (1.1) | 10 (0.9) | |
Normal | 805 (18.4) | 149 (13.8) | |
Overweight | 1602 (36.6) | 341 (31.7) | |
Obese | 1624 (37.1) | 467 (43.4) | |
Morbidly obese | 293 (6.7) | 109 (10.1) | |
Smoking | 0.399 | ||
Ever | 2195 (48.5) | 521 (47.1) | |
Never | 2333 (51.5) | 586 (52.9) | |
Serum LDL level | 0.182 | ||
≥ 190 mg/dl | 22 (0.6) | 9 (1.0) | |
< 190 mg/dl | 3652 (99.4) | 894 (99.0) | |
EGFR (race-adjusted) | 0.333 | ||
≥ 30 ml/min/1.73m2 | 3653 (99.3) | 905 (99.6) | |
< 30 ml/min/1.73m2 | 27 (0.7) | 4 (0.4) | |
Aspirin use | 0.529 | ||
Yes | 1073 (23.7) | 253 (22.8) | |
No | 3457 (76.3) | 857 (77.2) | |
Statin use | < 0.05 | ||
Yes | 2008 (44.3) | 450 (40.5) | |
No | 2522 (55.7) | 660 (59.5) | |
Antihypertensive use | 0.646 | ||
Yes | 4328 (95.5) | 1064 (95.9) | |
No | 202 (4.5) | 46 (4.1) | |
No. Antihypertensives | < 0.001 | ||
0 | 202 (4.5) | 46 (4.1) | |
1 | 1711 (37.8) | 347 (31.3) | |
2 | 1376 (30.4) | 321 (28.9) | |
3 or more | 1241 (27.4) | 396 (35.7) |